drugset / Trial / NCT07212946
Ayahuasca and Esketamine for Major Depression
RandomizedParallel-groupDouble-blindTreatment
Summary
Double-blind, randomized trial comparing 4 weekly doses of oral ayahuasca and esketamine in patients with major depression.
Timeline
- Start
- 2022-10-30
- Primary completion
- 2024-10-30
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ayahuasca | Traditional medicine (herbal / TCM) | — | Oral |
| Subject | Esketamine | Other / unclassified | — | Oral |